Audrey Fuller
Adult Health · Atlanta, GANPI 1104462316
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 346 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 51 manufacturers, the largest accounting for just 10.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,646 and has fallen 53.1% since, to $1,242 in 2025. Among adult health clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 346 payments — averaging $23.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$888
- Novo Nordisk$883
- Abbott$706
- Xeris Pharmaceuticals, Inc.$599
- Mannkind Corporation$565
- Insulet Corporation$524
- plus $4K from 45 others
What the payments were for
- Food & beverage$8,110100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iLet Bionic Pancreas$355
- t:slim X2 Insulin Pump with Control-IQ$342
- Omnipod$336
- Korlym$244
- CeQur Simplicity$184
- FreeStyle Libre 2$128
- Entyvio$125
- MOUNJARO$125
- EVENITY$122
- Ozempic$104
- RYBELSUS$104
How this compares
$8,122 in reported general payments places this provider in the 90th percentile of 577 adult health providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 134 | $165,467 |
| MounjaroTirzepatide | 59 | $84,119 |
| JardianceEmpagliflozin | 43 | $44,339 |
| FarxigaDapagliflozin Propanediol | 51 | $36,838 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 24 | $26,654 |
| TrulicityDulaglutide | 17 | $25,430 |
| RybelsusSemaglutide | 16 | $22,707 |
| JanuviaSitagliptin Phosphate | 17 | $19,414 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $18,849 |
| Tresiba Flextouch U-100Insulin Degludec | 36 | $18,261 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 21 | $15,621 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $8,620 |
| SynthroidLevothyroxine Sodium | 102 | $7,382 |
| TirosintLevothyroxine Sodium | 21 | $5,414 |
| Liothyronine Sodium | 65 | $3,207 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $883 | $188,174150 claims |
| Lilly USA, LLCMounjaro, Trulicity, Insulin Lispro | $888 | $111,936103 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $162 | $70,99267 claims |
| AstraZenecaFarxiga | $29 | $36,83851 claims |
| MerckJanuvia | $31 | $19,41417 claims |
| AbbVieSynthroid | $303 | $7,382102 claims |
| IBSA Pharma Inc.Tirosint | $58 | $5,41421 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid | $126 | $2,114205 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 577 adult health providers in Georgia.
Other adult health in Atlanta
- Patricia KeeganAtlanta$224K
- Diane WirthAtlanta$132K
- Barbara WeberAtlanta$74K
- Terry HackworthAtlanta$49K
- Jenina LagascaAtlanta$17K
- Caleb MagistroAtlanta$17K
- Charise GleasonAtlanta$14K
- Colleen LewisAtlanta$11K
- Dawnelle StedingAtlanta$9K
- Julie WebsterAtlanta$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.